Palmitoyl Serotonin Inhibits L-dopa-induced Abnormal Involuntary Movements in the Mouse Parkinson Model

L-3,4-dihydroxyphenylalanine (L-DOPA) is the most common treatment for patients with Parkinson's disease (PD). However, long term use of L-DOPA for PD therapy lead to abnormal involuntary movements (AIMs) known as dyskinesia. Fatty acid amide hydrolase (FAAH) is enriched protein in basal gangli...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hye-Yeon, Ryu, Young-Kyoung, Go, Jun, Son, Eunjung, Kim, Kyoung-Shim, Kim, Mee Ree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Brain and Neural Science 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999423/
https://www.ncbi.nlm.nih.gov/pubmed/27574484
http://dx.doi.org/10.5607/en.2016.25.4.174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999423/
https://www.ncbi.nlm.nih.gov/pubmed/27574484
http://dx.doi.org/10.5607/en.2016.25.4.174

Ejemplares similares